After falling into dispute, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) ( Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) . SZ) fell continuously.
On April 18, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) continued to fall by the limit to 32.39 yuan.
In fact, just a few days ago, on April 12, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) share price reached the highest point of 43.12 yuan since listing. By April 18, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) market value had evaporated by 17 billion.
As a double Bull Stock, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) has also been concerned by many public funds.
According to combing, by the end of 2021, there were 177 funds holding Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) , including 65 fund companies. 177 funds hold Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) 48260700 shares, with a total market value of 946 million.
"Although the company still held shares at the end of last year, there were not many positions in the first quarter of this year." On April 18, a relevant person of a large public fund told the 21st Century Business Herald reporter.
Now it seems that the position adjustment in the first quarter of this year has become the key to test the organization. Who accurately escaped the top and who may be buried?
positions of 65 fund companies Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603)
At present, the first quarterly report of public funds has not been fully disclosed. According to the annual report data of 2021, a total of 177 funds hold Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) , 482607 million shares, accounting for 3.51% of the outstanding shares, and the total market value of the shares is 946 million.
Compared with the interim report data of 2021, the number of fund companies holding Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) at the end of 2021 was still 65, but the number of funds held changed from 195 to 177, a decrease of 18; The total shareholding changed from 4335006 million shares to 482607 million shares, an increase of 4.9101 million shares; The proportion of shares held in circulating shares changed from 4.41 to 3.51%, a decrease of 0.9 percentage points.
According to the fund companies, at the end of 2021, the fund company holding the largest number of Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) shares was Xingzheng Global Fund, followed by China Southern Fund, Hua'an fund, Cathay Pacific Fund and Great Wall Fund. The five fund companies held more than 2.5 million Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) shares.
Overall, compared with the middle of 2021, the number of fund companies holding more than 1 million Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) shares at the end of 2021 increased from 10 to 13. In addition to the above five fund companies, there are huitianfu fund, Qianhai Kaiyuan fund, Tianhong fund, Fuguo fund, Everbright Prudential fund, noan fund, Western Lide fund and fuanda fund.
"As it is an index fund, it has a large scale, so it holds a large number of constituent stocks, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) is a constituent stock, so it is difficult to avoid." A person concerned of a holding fund company said.
After the outbreak of the dispute, it is not uncommon for institutions to flee.
Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) 4 / 15: the top four seats sold on that day were institutional seats, and the total net sales of the four institutional seats exceeded 800 million.
In fact, from the perspective of heavy holdings, at the end of 2021, there were 13 funds with heavy holdings Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) . Compared with four in the third quarter of 2021, it has doubled.
Among them, the active funds include the selection of Qianhai Kaiyuan traditional Chinese medicine research, Everbright baodexin health plus, fuanda's advantageous growth, Dacheng Hengxiang's one-year opening of Chunxiao, Zhejiang Huijin's quantitative selection, etc. The market value of Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) held by Qianhai Kaiyuan traditional Chinese Medicine Research Co., Ltd. accounts for more than 8% of the net value, which is the largest fund.
From the perspective of fund companies, Qianhai open source fund, huitianfu fund, Everbright Prudential fund and fuanda fund hold more than one million shares.
position strategy difference
In fact, in the second half of last year, the position strategies of fund companies for Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) were also different.
The 21st Century Business Herald reporter found that Xingzheng Global Fund had significantly reduced its holdings of Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) . From 20276500 shares at the end of June last year, 11831800 shares were reduced to 8444700 shares, a reduction of 58%.
However, Xingzheng Global Fund is still the fund company with the largest number of Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) shares. By the end of 2021, Xingzheng Global Fund held 0.61% of the outstanding shares, with a market value of 1655155 million yuan, accounting for 0.03% of the net value and 0.08% of the market value of stock investment.
At the end of 2021, the three funds of Xingquan Heyuan, Xingquan Hexing closed operation for two years and Xingquan global vision under Xingzheng Global Fund held more than one million shares of Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) with the number of shares of 2783300 shares, 2386300 shares and 1733100 shares respectively.
Among them, the number of shares held by xingquanheyuan in the past two years is second only to China Southern Securities 500etf, which is the largest China Securities 500etf in the market.
Qianhai Kaiyuan research and selection of traditional Chinese medicine is the active equity fund with the second largest shareholding. At the end of 2021, the fund held 2427600 shares Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) .
In fact, the selection of Qianhai Kaiyuan traditional Chinese medicine research increased significantly in the second half of last year Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) . At the end of June 2021, the fund held only 267800 Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) shares.
It is worth mentioning that Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) share price has fluctuated downward since the second half of last year, and Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) share price has risen rapidly since the beginning of this year.
According to the current data, many fund companies such as Hua'an fund and Great Wall Fund accelerated the admission in the second half of last year.
In the second half of last year, the number of shares of Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) held by Hua'an fund increased by 4471200 shares, from 39700 shares to 4510900 shares, and the number of shares jumped from the 31st place at the end of June last year to the third place at the end of last year.
By the end of 2021, the shareholding of Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) held by Hua'an fund accounted for 0.33% of the outstanding shares, the market value of the shareholding was 88.413 million yuan, accounting for 0.02% of the net value and 0.05% of the market value of stock investment.
In the second half of last year, Great Wall Fund increased its holdings of 2.743 million shares Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) , from 30700 shares to 2.7737 million shares, and the number of shares jumped from the 36th at the end of June last year to the fifth at the end of last year.
By the end of 2021, the shareholding of Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) held by Great Wall Fund accounted for 0.20% of the outstanding shares, with a market value of 543643 million yuan, accounting for 0.03% of the net value and 0.16% of the market value of stock investment.
On the contrary, Jingshun Great Wall Fund significantly reduced its holdings of Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) .
In the second half of last year, Jingshun Great Wall Fund reduced its holdings of 1548000 shares Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) , and the number of shares held changed from 1562900 shares to 14900 shares. The number of shares held fell from sixth to 44th.
By the end of 2021, the stock market value of Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) held by Jingshun Great Wall Fund was only 292400 yuan.
